Skip to main content
OpenTrials

Clinical trial condition

Bronchial Diseases

Explore clinical trials studying Bronchial Diseases. Study availability and eligibility vary by location and protocol.

4,802 public trials 451 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Diseases trial results

Completed

Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic Leukemia

NCT02388048

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +24 more
Locations
  • Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Provincia, Italy
  • S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Area Vasta N. 5 Ascoli Piceno - S. Benedetto Del Tronto, Presidio Ospedaliero Av5 Osp. Gen. Prov.Le "C.G.Mazzoni" - Uoc Ematologia Ascoli Piceno, Italy
  • Nuovo Record Esporta in Excel Stampa Esporta in file di testo Mostra Informazioni Record Multi edit Stato dello studio presso il centro records: 28 Record 1/28 su 28 direzione di ordinamento Centro (CIC) direzione di ordinamento Sperimentatore Pri Bologna, Italy
View all 35 locations
View Trial Details
Completed

Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)

NCT04716075

Conditions
Adverse Event, Bronchial Diseases, Bronchiolitis, +33 more
Locations
  • Szpital Kliniczny Przemienienia Pańskiego, Oddział Hematologii i Transplantacji Szpiku Poznan, Greater Poland Voivodeship, Poland
  • Instytut Hematologii i Transfuzjologii Warsaw, Masovian Voivodeship, Poland
  • Narodowy Intytut Onkologii im. M. Skłodowskiej-Curie Oddział w Krakowie, Pododdział Leczenia Nowotworów Układu Chłonnego Krakow, Małopolska, Poland
  • Klinika Transplantacji Szpiku i Onkohematologii; Centrum Onkologii Instytut im. M.Sklodowskiej-Curie, Oddz. w Gliwicach Gliwice, Silesian Voivodeship, Poland
View Trial Details
Completed

A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab

NCT04159519

Conditions
Asthma, Bronchial Diseases, Eosinophilia, +13 more
Locations
  • Research Site Brest, France
  • Research Site Dijon, France
  • Research Site Le Kremlin-Bicêtre, France
  • Research Site Lille, France
View all 23 locations
View Trial Details
Completed

A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent Asthma

NCT01152450

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • 205.420.43002 Boehringer Ingelheim Investigational Site Linz, Austria
  • 205.420.43004 Boehringer Ingelheim Investigational Site Schlüsslberg, Austria
  • 205.420.43003 Boehringer Ingelheim Investigational Site Thalheim bei Wels, Austria
  • 205.420.43001 Boehringer Ingelheim Investigational Site Wels, Austria
View all 15 locations
View Trial Details

Related conditions